Intrathecal Rituximab in Progressive Multiple Sclerosis

Trial Profile

Intrathecal Rituximab in Progressive Multiple Sclerosis

Phase of Trial: Phase II

Latest Information Update: 05 Oct 2017

At a glance

  • Drugs Rituximab (Primary) ; Rituximab (Primary) ; Methylprednisolone
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Acronyms EFFRITE
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 14 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top